Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,088 total articles
Procter & Gamble (PG) looks attractive for a tactical long after management's comment that the worst is behind it and recent share strength. The company still generates strong free cash flow ($14.85B) and carries a $341B market cap with a reasonable P/E of ~21. Use a disciplined entry and stop, watch Q3 top-line and volume trends, and treat the pos…
Zscaler trades well below its 52-week high after a sector selloff. Fundamental demand for zero-trust and AI-protection of enterprise infrastructure supports double-digit revenue and FCF expansion. Valuation is rich but tractable given $946.8M in free cash flow and a $22.2B enterprise value. This trade targets a measured rebound to $190 over a 180-t…
Ethos Technologies looks like a cheap growth story on paper — low headline valuation and visible growth runway — but the stock is execution-sensitive. This trade targets a tactical rebound if upcoming operational milestones and improved transparency come through; stop tight enough to limit downside if results disappoint.
ASML beat Q1 2026 and raised full-year revenue guidance to 8-40 billion with a gross margin band of 51-53%. We view the lower margin band not as weakness but as confirmation ASML will prioritize system shipments and service revenue to capture structurally higher AI capex. Technicals and short-interest dynamics fav…
T1 Energy appears to be navigating a near-term earnings and cash-flow lull that the market is treating as permanent. We see this as a bridge year that creates an attractive asymmetric long trade: defined risk at $9.75, initial take-profit at $18.00. Macro headwinds (weak oil prices) and delayed capex are clouding sentiment today, but operational no…
Lundin Mining offers direct exposure to a multi-year copper bull thesis driven by electrification and constrained new supply. The stock can rally sharply on a sustained copper upswing, but company-specific operational and jurisdictional risks can quickly erase gains. This trade idea lays out an entry at $8.50, a protective stop at $6.50 and a reali…
Valero (VLO) pulled back after Iran announced the Strait of Hormuz was open, but the company’s industry-leading utilization, strong free cash flow and modest leverage argue that this pullback is a tactical entry. I lay out an actionable trade with entry, stop and target, plus the drivers that should keep refining profitability elevated even if crud…
MARA Holdings trades at a $4.4 billion market cap with an enterprise value near $7.47 billion, negative earnings, and heavy cash burn. Recent partnership moves to convert mining capacity into AI data centers, combined with elevated short interest and strong technical momentum, create a tradeable setup for a re-valuation. This idea lays out an entry…
ATI is trading near its 52-week high as aerospace production and advanced materials demand accelerate. Fundamentals show improving margins and strong ROE, but valuation is rich. This mid-term trade aims to capture further re-rating while protecting capital with a tight stop.
Fair Isaac (FICO) has been punished this spring, creating a tradeable opportunity. The company generates roughly $750m in free cash flow, trades at a market cap near $25.4B, and still commands pricing power in credit scoring and decisioning. Short-term sentiment has been weak, but a measured long with a $950 stop and a $1,500 target offers a favora…
Applied Materials is translating robust AI-driven wafer demand into outsized margin expansion and free cash flow. With a $315B market cap, ROE north of 36% and free cash flow of $6.2B, the stock looks set to outgrow peers. This trade targets a move above $450 over the next 46-180 trading days while keeping a tight stop below the 50-day support band…
DBV's VIASKIN Peanut patch posted strong Phase 3 VITESSE data in young children and the company is preparing a BLA submission in H1 2026. The stock already trades like a small-commercial biotech; our trade idea bets on approval and early commercial traction over the next 180 trading days while protecting downside with a disciplined stop.
lululemon has been punished from its 2025 peak but still runs a high-return, low-debt business. Valuation now looks detached from underlying cash flow and ROE. This trade idea uses a $165 entry, $150 stop and $240 target over a 180-trading-day turnaround horizon.
Sivers Semiconductors is a small, execution-sensitive supplier of optical components positioned to benefit from rising AI datacenter demand for short-reach optics and VCSEL-based interconnects. This trade idea frames Sivers as a tactical long: buy on weakness with strict stops and a mid-to-long-term time frame to allow product qualifications and vo…
Gevo is sequencing commercial wins (45Z tax credits, carbon credit sales) and partnerships to scale sustainable aviation fuel (SAF) production. The stock is trading at $1.70 with an EV of ~$502M and shows oversold technicals; this trade targets a rebound toward structural resistance as the company converts credits and partnerships into near-term ca…
ALSMY has been punished despite strong commercial momentum: record order intake, a €100.3bn backlog and confirmed FY guidance. Technicals show oversold conditions and heavy short activity — a setup for a mean-reversion trade with asymmetric upside. Trade plan below targets a constructive recovery over the next 46-180 trading days while protecting c…
lululemon's recent product cadence appears to be re-accelerating full-price sell-throughs. The stock trades at roughly $167, supported by strong free cash flow, a sub-13x P/E and an EV/EBITDA near 6.3x. We outline an actionable long trade with entry, stop and target and the key catalysts and risks to watch over the next 180 trading days.
BMY trades like a dividend defensive with legacy revenue fading, but cash flow, a 4.2% yield and material pipeline/collaboration wins argue for a re-rate. This trade targets a 20%+ upside over a 180 trading-day horizon while respecting balance sheet and patent risk with a tight stop.
Appian looks set for an asymmetric short-to-mid-term trade: fundamentals show meaningful AI-driven revenue acceleration and positive cash flow, valuation is reasonable on an EV/S basis, and technicals plus elevated short interest set the stage for an outsized move on a clean earnings beat. Entry $21.50, target $30.00, stop $18.50; mid term (45 trad…
Roku is trading near a 52-week high after a string of execution beats, profitability and a sharp free cash flow improvement. Valuation looks rich on headline P/E but the company’s platform economics, $478M of trailing free cash flow and a $17.1B market cap leave room for a tactical long while AI-driven ad targeting and distribution partnerships com…
Compass Pathways (CMPS) remains a high-conviction long. Positive Phase 3 data and a meaningful 2026 psilocybin production quota increase have re-rated the stock; at ~$6.62 today the market cap (~$636M) offers asymmetric upside versus a still-small public float and an analyst community bullish on peak sales. This trade idea lays out an entry, stop a…
ChargePoint is showing early signs of stabilization: revenue beats, improving gross margins, shrinking operating losses, and bullish technicals. With a market cap near $152M and EV/sales roughly 0.66, the risk/reward looks attractive for a mid-term swing trade. I’m upgrading my rating and proposing a trade plan with entry at $6.24, stop at $5.25 an…
Ubisoft has underperformed its peers through execution missteps and a heavy release cadence that failed to consistently convert into profitable growth. The company still controls valuable franchises and multiple near-term catalysts that could re-accelerate revenue and margin expansion. This trade idea lays out a long entry, risk controls and the sc…
Camtek's industry position in semiconductor inspection, a recent run-up to a 52-week high, and continuing technical momentum justify a tactical long. I'm recommending a mid-term (45 trading days) buy at current levels with a clear stop and target to manage risk and capture further upside from AI-driven chip demand and inspection market growth.
CoreWeave just converted a major uncertainty into a competitive advantage: multiyear deals and an $88 billion backlog give revenue visibility for years, reducing counterparty/capacity risk and making the stock actionable for a long-term core position. Valuation is rich today (market cap ~$62.1B, EV/Sales ~16x), so size thoughtfully and use a clear …
